{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:26:51Z","timestamp":1787023611451,"version":"build-2736575974"},"reference-count":48,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.18632\/aging.206021","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T11:34:51Z","timestamp":1721388891000},"page":"11385-11408","source":"Crossref","is-referenced-by-count":7,"title":["Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer"],"prefix":"10.18632","volume":"16","author":[{"given":"Jia","family":"Wang","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College, Kunming Medical University, Kunming, China"},{"name":"Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Li","sequence":"additional","affiliation":[{"name":"Core Facility for Protein Research, Chinese Academy of Sciences, Beijing, China"},{"name":"Zhongke Jianlan Medical Research Institute, Beijing, China"},{"name":"Zhejiang Institute of Integrated Traditional and Western Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqin","family":"Zhan","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Kunming Medical University, Kunming, China"},{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Kunming Medical University, Kunming, China"},{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihao","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Kunming Medical University, Kunming, China"},{"name":"Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1038\/s41467-022-33980-9","article-title":"Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.","volume":"1","author":"Quale","year":"2022","journal-title":"Nat Commun"},{"key":"2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.","volume":"7","author":"Veskim\u00e4e","year":"2021","journal-title":"Eur Urol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-18-1656","article-title":"Long Noncoding RNAInhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2.","volume":"2","author":"Lin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jare.2021.11.010","article-title":"Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives.","volume":"3","author":"Lin","year":"2022","journal-title":"J Adv Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020.","volume":"7","author":"Galsky","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"7","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1200\/JCO.2017.72.8444","article-title":"Immune Checkpoint Blockade in Metastatic Urothelial Cancer.","volume":"3","author":"Balar","year":"2017","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.","volume":"8","author":"Chen","year":"2016","journal-title":"Sci Transl Med"},{"key":"9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.eururo.2018.03.015","article-title":"Improving the Cost Efficiency of PD-1\/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?","volume":"7","author":"Necchi","year":"2018","journal-title":"Eur Urol"},{"key":"10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment.","volume":"2","author":"Coussens","year":"2012","journal-title":"Cancer Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2020.02.006","article-title":"Breast cancer models: Engineering the tumor microenvironment.","volume":"10","author":"Zorlutuna","year":"2020","journal-title":"Acta Biomater"},{"key":"12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","article-title":"Tumor microenvironment: barrier or opportunity towards effective cancer therapy.","volume":"2","author":"Lin","year":"2022","journal-title":"J Biomed Sci"},{"key":"13","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-17-0784","article-title":"Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGF\u03b2 Signaling.","volume":"1","author":"Pouliot","year":"2018","journal-title":"Mol Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"101417","DOI":"10.1016\/j.smim.2020.101417","article-title":"Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.","volume":"4","author":"Mechta-Grigoriou","year":"2020","journal-title":"Semin Immunol"},{"key":"15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.","volume":"3","author":"Kuperstein","year":"2018","journal-title":"Cancer Cell"},{"key":"16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.trecan.2019.09.009","article-title":"Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.","volume":"5","author":"De Wever","year":"2019","journal-title":"Trends Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"1000888","DOI":"10.3389\/fonc.2022.1000888","article-title":"A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer.","volume":"1","author":"Wilkins","year":"2022","journal-title":"Front Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.","volume":"17","author":"Dao","year":"2018","journal-title":"Cell"},{"key":"19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments.","volume":"2","author":"Storey","year":"2012","journal-title":"Bioinformatics"},{"key":"20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.","volume":"55","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-8794-3-21","article-title":"SEURAT: visual analytics for the integrated analysis of microarray data.","volume":"3","author":"Unwin","year":"2010","journal-title":"BMC Med Genomics"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP.","author":"Newell","year":"2018","journal-title":"Nat Biotechnol"},{"key":"23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage.","volume":"2","author":"Bhattacharya","year":"2019","journal-title":"Nat Immunol"},{"key":"24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.","volume":"2","author":"Hayes","year":"2010","journal-title":"Bioinformatics"},{"key":"25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"26","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.18632\/aging.102931","article-title":"Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.","volume":"1","author":"Wu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"1","author":"He","year":"2012","journal-title":"OMICS"},{"key":"28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer.","volume":"2","author":"Koeffler","year":"2018","journal-title":"Genome Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels.","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"30","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2020.00784","article-title":"The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.","volume":"1","author":"Fridman","year":"2020","journal-title":"Front Immunol"},{"key":"31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-020-02649-x","article-title":"Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).","volume":"7","author":"Tian","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"32","doi-asserted-by":"publisher","first-page":"e002467","DOI":"10.1136\/jitc-2021-002467","article-title":"Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.","volume":"9","author":"Rong","year":"2021","journal-title":"J Immunother Cancer"},{"key":"33","doi-asserted-by":"publisher","first-page":"850745","DOI":"10.3389\/fimmu.2022.850745","article-title":"Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing.","volume":"1","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"34","doi-asserted-by":"publisher","first-page":"992990","DOI":"10.3389\/fimmu.2022.992990","article-title":"Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma.","volume":"1","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"35","doi-asserted-by":"publisher","first-page":"581459","DOI":"10.3389\/fonc.2020.581459","article-title":"HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium.","volume":"1","author":"Sukumar","year":"2021","journal-title":"Front Oncol"},{"key":"36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cac2.12274","article-title":"The Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells.","volume":"4","author":"Sun","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"37","doi-asserted-by":"publisher","first-page":"638099","DOI":"10.3389\/fonc.2021.638099","article-title":"A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer.","volume":"1","author":"Han","year":"2021","journal-title":"Front Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1007\/s12011-022-03510-1","article-title":"Fibronectin 1 as a Key Gene in the Genesis and Progression of Cadmium-Related Bladder Cancer.","volume":"20","author":"Zhu","year":"2023","journal-title":"Biol Trace Elem Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fmolb.2020.00202","article-title":"Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer.","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Mol Biosci"},{"key":"40","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.3892\/ol.2020.11841","article-title":"High expression of EMP1 predicts a poor prognosis and correlates with immune infiltrates in bladder urothelial carcinoma.","volume":"2","author":"Yang","year":"2020","journal-title":"Oncol Lett"},{"key":"41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-021-01989-5","article-title":"Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.","volume":"4","author":"Lin","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.","volume":"8","author":"Lin","year":"2023","journal-title":"Cancer Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","article-title":"Cytotoxic CD4T cells in cancer: Expanding the immune effector toolbox.","volume":"5","author":"Fong","year":"2021","journal-title":"Immunity"},{"key":"44","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8cytotoxic T lymphocytes in cancer immunotherapy: A review.","volume":"23","author":"Mortezaee","year":"2019","journal-title":"J Cell Physiol"},{"key":"45","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer.","volume":"5","author":"Luster","year":"2021","journal-title":"Immunity"},{"key":"46","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3892\/or.2010.1019","article-title":"VEGFR and EGFR inhibition increases epithelial cellular characteristics and chemotherapy sensitivity in mesenchymal bladder cancer cells.","volume":"2","author":"Flaig","year":"2010","journal-title":"Oncol Rep"},{"key":"47","doi-asserted-by":"publisher","first-page":"109273","DOI":"10.1016\/j.cbi.2020.109273","article-title":"Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells.","volume":"33","author":"Jin","year":"2020","journal-title":"Chem Biol Interact"},{"key":"48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12885-022-09376-9","article-title":"PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth.","volume":"2","author":"Nadiminty","year":"2022","journal-title":"BMC Cancer"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T13:37:55Z","timestamp":1722865075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":48,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7,31]]}},"alternative-id":["206021","39033778"],"URL":"https:\/\/doi.org\/10.18632\/aging.206021","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}